The B-cell Inhibitors Market has established itself as a crucial component of modern pharmaceutical development, fueled by rising autoimmune disorder cases such as rheumatoid arthritis, lupus, and multiple sclerosis. B-cell inhibitors are specialized biologic therapies designed to target B-cells, which are instrumental in triggering hyperactive immune responses characteristic of these...